SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Divi's Laboratories informs about notice of postal ballot

04 Mar 2024 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to the outcome of meeting of the Board of Directors dated February 10, 2024, Divi's Laboratories has submitted the Postal Ballot Notice dated February 10, 2024 (Notice) to seek approval of Members of the Company for the following resolutions: Reappointment of Prof. Sunaina Singh (DIN: 08397250) as an Independent Director of the Company Special Resolution; Appointment of Dr. S. Devendra Rao (DIN: 10481393) as Whole-time Director, designated as ‘Whole-time Director (Manufacturing)’ of the Company and approval of the remuneration payable to him; and approval to hold and continue to hold office or place of profit by S. Swaroop Krishna in the Company. The e-voting period commences on Wednesday, March 06, 2024, at 9:00 am (IST) and ends on Thursday, April 04, 2024, at 5.00 pm (IST). The e-voting shall be disabled by Kfintech for e-voting thereafter. Results of the Postal Ballot will be announced on or before 5.00 pm (IST) on or before Saturday, April 06, 2024. The Postal Ballot Notice along with e-voting instructions is available on the Company’s website at https://www.divislabs.com and on the website of Kfintech https://evoting.kfintech.com.

The above information is a part of company’s filings submitted to BSE.

Divis Lab Share Price

6281.35 52.40 (0.84%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×